Isolation and structural elucidation of novel degradant during degradation study of Azilsartan kamedoxomil

Anil Kumar Guduri , Vundavilli Jagadeesh Kumar , P.Badarinadh Gupta , Julakanti Shashidar Reddy , Kishore Babu Bonige , Hemant Kumar Sharma
{"title":"Isolation and structural elucidation of novel degradant during degradation study of Azilsartan kamedoxomil","authors":"Anil Kumar Guduri ,&nbsp;Vundavilli Jagadeesh Kumar ,&nbsp;P.Badarinadh Gupta ,&nbsp;Julakanti Shashidar Reddy ,&nbsp;Kishore Babu Bonige ,&nbsp;Hemant Kumar Sharma","doi":"10.1016/j.jpbao.2024.100032","DOIUrl":null,"url":null,"abstract":"<div><p>To investigate the stability of Azilsartan kamedoxomil (AKM) under stress conditions and to identify the degradation products, it was subjected to force degradation/stress under basic, acidic, oxidative, thermal, humidity, and photolytic conditions as per international council for harmonisation (ICH) guidelines. AKM degradation was found under basic, acidic, oxidative, thermal, photolytic, and humidity stress. Separation of the four degradation products of AKM was carried out utilizing a C-18 column, employing preparative High-performance liquid chromatography (HPLC) and gradient mode elution. The structures were elucidated with spectroscopic HRMS, 1D, and 2D NMR and the products were identified as <em>2-hydroxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol −3-yl)[1,1′-biphenyl]-4-yl]-methyl]-1 H-benzimidazole-7-carboxylic acid</em> (AKMDP-1), 2<em>-ethoxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1 H-benzimidazole-7-carboxylic acid</em> (AKMDP-2), <em>(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-hydroxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)[1,1′-biphenyl]-4-yl]methyl]-1 H-benzimidazole-7-carboxylate</em> (AKMDP-3) and <em>2-hydroxy-3-oxobutyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1′-biphenyl]-4-yl)methyl)-1 H-benzo[d]imidazole-7-carboxylate</em> (AKMDP-4). Out of them, two degradants AKMDP-1 and AKMDP-3 were reported earlier, AKMDP-2 was one of the process intermediate (Azilsartan) used in the preparation of Azilsartan kamedoxomil.</p></div>","PeriodicalId":100822,"journal":{"name":"Journal of Pharmaceutical and Biomedical Analysis Open","volume":"4 ","pages":"Article 100032"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949771X24000082/pdfft?md5=9383b0112254ebad0cd5103d8732f5df&pid=1-s2.0-S2949771X24000082-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical and Biomedical Analysis Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949771X24000082","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

To investigate the stability of Azilsartan kamedoxomil (AKM) under stress conditions and to identify the degradation products, it was subjected to force degradation/stress under basic, acidic, oxidative, thermal, humidity, and photolytic conditions as per international council for harmonisation (ICH) guidelines. AKM degradation was found under basic, acidic, oxidative, thermal, photolytic, and humidity stress. Separation of the four degradation products of AKM was carried out utilizing a C-18 column, employing preparative High-performance liquid chromatography (HPLC) and gradient mode elution. The structures were elucidated with spectroscopic HRMS, 1D, and 2D NMR and the products were identified as 2-hydroxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol −3-yl)[1,1′-biphenyl]-4-yl]-methyl]-1 H-benzimidazole-7-carboxylic acid (AKMDP-1), 2-ethoxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1 H-benzimidazole-7-carboxylic acid (AKMDP-2), (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-hydroxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)[1,1′-biphenyl]-4-yl]methyl]-1 H-benzimidazole-7-carboxylate (AKMDP-3) and 2-hydroxy-3-oxobutyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1′-biphenyl]-4-yl)methyl)-1 H-benzo[d]imidazole-7-carboxylate (AKMDP-4). Out of them, two degradants AKMDP-1 and AKMDP-3 were reported earlier, AKMDP-2 was one of the process intermediate (Azilsartan) used in the preparation of Azilsartan kamedoxomil.

阿齐沙坦卡美哆米降解研究中新型降解剂的分离与结构鉴定
为研究阿齐沙坦卡美哆米(AKM)在应力条件下的稳定性并确定降解产物,根据国际协调理事会(ICH)指南,在碱性、酸性、氧化、热、湿度和光解条件下对其进行了力降解/应力测试。AKM 在碱性、酸性、氧化、热、光解和湿度应力条件下均发生降解。采用制备型高效液相色谱法(HPLC)和梯度洗脱模式,利用 C-18 色谱柱分离了 AKM 的四种降解产物。利用光谱 HRMS、1D 和 2D NMR 阐明了这些产物的结构,并确定其为 2-羟基-1-[[2′-(5-氧代-4,5-二氢-1,2,4-恶二唑-3-基)[1、1′-联苯-4-基]-甲基]-1 H-苯并咪唑-7-羧酸(AKMDP-1),2-乙氧基-1-[[2′-(5-氧代-4,5-二氢-1,2,4-恶二唑-3-基)联苯-4-基]甲基]-1 H-苯并咪唑-7-羧酸(AKMDP-2)、(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-hydroxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)[1,1′-联苯]-4-基]甲基]-1 H-苯并咪唑-7-羧酸酯(AKMDP-3)和 2-羟基-3-氧代丁基 2-乙氧基-1-[(2′-(5-氧代-4、5-二氢-1,2,4-恶二唑-3-基)-[1,1′-联苯]-4-基)甲基)-1 H-苯并[d]咪唑-7-羧酸酯(AKMDP-4)。其中两种降解剂 AKMDP-1 和 AKMDP-3 早先已有报道,AKMDP-2 是用于制备阿齐沙坦卡美哆米的中间体(阿齐沙坦)之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信